Gyre Therapeutics (GYRE) Capital Expenditures (QoQ) (2010 - 2026)
Gyre Therapeutics (GYRE) Capital Expenditures (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Gyre Therapeutics |
554.75 Mn |
540.62 Mn |
8.38 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
23.61% |
| Dec 31, 2025 |
-78.44% |
| Sep 30, 2025 |
160.94% |
| Jun 30, 2025 |
109.84% |
| Mar 31, 2025 |
287.69% |
| Dec 31, 2024 |
-109.38% |
| Sep 30, 2024 |
-52.40% |
| Jun 30, 2024 |
530.30% |
| Mar 31, 2024 |
-90.06% |
| Dec 31, 2023 |
17.73% |
| Sep 30, 2023 |
-20.31% |
| Jun 30, 2023 |
42.19% |
| Sep 30, 2020 |
1,118.75% |
| Jun 30, 2020 |
-5.88% |
| Mar 31, 2020 |
1,800.00% |
| Dec 31, 2019 |
-200.00% |
| Sep 30, 2019 |
-97.96% |
| Jun 30, 2019 |
226.67% |
| Mar 31, 2019 |
-91.43% |
| Jun 30, 2018 |
-98.48% |
